-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Recent Healthcare Stocks Articles
A New Healthcare Stock Pick in the Industry of the Decade
This company is riding a powerful trend in the future of healthcare. Plus, it offers high growth, a huge potential market and a path to profitability.
Biotech Boom: The Race for COVID-19 Vaccines
The pandemic highlights how far medical science has come. It also highlights how exciting the future is. While the Year of Biotech has been outstanding so far, we’re only seeing the beginning of a revolution.
GrowGeneration Stock Is an Attractive Play on U.S. Cannabis
GRWG stock has soared this year, with strong Q2 results a key reason why. Cannabis and organic demand should drive further upside.
Where to Invest Now for Massive Returns
Investing in these big themes early -- marijuana legalization and self-driving vehicles -- will return you over 10 times your money over the coming years.
The Clear Leader in the Huge Telehealth Trend
The newly combined company of Teladoc and Livongo is the clear leader in the hypergrowth telehealth trend. Here's why.
Royalty Pharma’s Cash Flow Growth Will Power the Stock Higher
Royalty Pharma's cash flow growth will power the stock higher. If cash flow continues at this pace, RPRX stock could rise by at least 88% over the next three years.
The Long THC-Short CBD Cannabis Trade Is Paying Off
Marijuana stocks have struggled in the past eight months. Going long THC stocks and short CBD stocks is a good way to bet on cannabis while mitigating risk.
Biotech Stocks: This Sector Outperformed the Market in Q2
Biotech stocks are breaking out of a seven-year consolidation phase -- and fast. But this rally isn’t slowing down anytime soon.
Buy Canopy Growth Stock Before Positive Momentum Returns
A major needle-mover around the corner could lead CGC stock to trend higher again. Get ahead of the crowd by buying today's pullback.
Enough Already! Ditch Moderna Stock
Whether you bought MRNA stock for the CMV or the coronavirus catalyst, it’s clearly time to sell. With shares appearing to be topping out, cashing out today could be the best call.